drugset / Trial / NCT01867255
Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels
NaSingle-groupOpen-labelBasic science
Summary
The purpose of the study is to determine whether a significant and predictable change in bioavailability of extended-release venlafaxine occurs following Roux-en-Y gastric bypass.
Timeline
- Start
- 2013-10
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Venlafaxine | Small molecule | 75 mg | — |
Indications
No indication recorded.